2020
ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer.
Chen W, Winer E, Ballman K, Partridge A, Carey L, Carvan M, Matyka C, Openshaw T, Visvanathan K, Symington B, Holmes M. ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer. Journal Of Clinical Oncology 2020, 38: tps600-tps600. DOI: 10.1200/jco.2020.38.15_suppl.tps600.Peer-Reviewed Original ResearchInvasive disease-free survivalAspirin usersCardiovascular diseaseBreast cancerHER2-negative breast cancer patientsBlinded placebo-controlled trialHER2-negative breast cancerNegative breast cancer patientsRandomized phase IIIRegular aspirin usersPlacebo-controlled trialDisease-free survivalHormone receptor statusDouble-blinded fashionMonths of diagnosisBreast cancer survivorsTime of presentationBody mass indexBreast cancer patientsTherapy-Breast CancerBreast cancer survivalMultiple epidemiologic studiesNegative breast cancerAnti-tumor effectsDaily aspirin
2009
Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
Breech L, Braverman P. Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder. International Journal Of Women's Health 2009, 1: 85-95. PMID: 21072278, PMCID: PMC2971718, DOI: 10.2147/ijwh.s4338.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsOral contraceptive pillsPremenstrual dysphoric disorderPlacebo-controlled trialContraceptive pillsDysphoric disorderTherapeutic modalitiesLarge randomized placebo-controlled trialsLow-dose oral contraceptive pillDouble-blind placebo-controlled trialBlinded placebo-controlled trialNew oral contraceptive pillRandomized placebo-controlled trialTreatment of PMDDFluid retention symptomsOpen-label studyReproductive-age womenSignificant placebo effectMultiple therapeutic modalitiesBetter patient compliancePromising therapeutic modalityNovel progestinRetention symptomsBlood pressureSerum potassiumThrombotic events
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply